METHOD FOR SELECTING ANTIBODY FRAGMENTS, RECOMBINANT ANTIBODIES PRODUCED THEREFROM, AND USES THEREOF IN DIAGNOSING INFLUENZA VIRUS
Updated time: 2023-12-01 14:13:06
METHOD FOR SELECTING ANTIBODY FRAGMENTS, RECOMBINANT ANTIBODIES PRODUCED THEREFROM, AND USES THEREOF IN DIAGNOSING INFLUENZA VIRUS
Docket Number
28A-1090917
Announcement Date
2021-01-15
IP Status
TW I820716、PCT filing (PCT/US22/29893)
Abstract
The invention is methods for selecting an antibody fragment specific to influenza A virus (IAV) or influenza B virus (IBV). Also disclosed herein are recombinant antibodies produced from the selected antibody fragments, and uses thereof in the diagnosis and treatment of IAV or IBV infection.
Technological Advantages
- Antibodies are not limited to animal immune response, can produce a wide range of antibodies in a short time.
- Produce discriminating antibodies even against highly similar antigens.
- Use different antibody combinations to detect different virus subtypes and avoid misjudgment.
Applications of Technology
- Rapid detection kits of influenza virus
- Combination of rapid test kits for upper respiratory tract infection (corona virus and influenza virus, for example)
Inventor
An-Suei Yang, Chung-Ming Yu, Chao-Ping Tung, Horng-Ru Hsu, Hung-Pin Peng, Chi-Yung Chen, Yu-Chuan Huang, Pei-Hsun Tsai, Szu-Yu Lin, Fei-Hung Hung.
Contact person
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office

METHOD FOR SELECTING ANTIBODY FRAGMENTS, RECOMBINANT ANTIBODIES PRODUCED THEREFROM, AND USES THEREOF IN DIAGNOSING INFLUENZA VIRUS